Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.234ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.234ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.234NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.231ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.231ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.231ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.231NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.243ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.243ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.243ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.243NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.517ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.517ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.517ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.517NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.291ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.291ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.291ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.291NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
B.1.258ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.349ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.349ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.349ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.349NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.314ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.314ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.314ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.314NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.132ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.132ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.132ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.132NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.42ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.42NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
K.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
K.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
K.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
K.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.56ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used